Adhering to current clinical guidance supports evidence-based assessment, informs decision-making, and helps reduce complications in patients living with non-small cell lung cancer (NSCLC). Ongoing review of recommendations and guidance enables clinicians to improve evaluation and management, which supports better patient outcomes.

Today's rundown features clinical guidance regarding NSCLC from societies like the American Society of Clinical Oncology (ASCO), Society of Thoracic Surgeons (STS), European Society for Medical Oncology (ESMO), and others. The following clinical guidance is arranged by publication date and sorted into three categories including surgical management of NSCLC and Stage IV NSCLC.

Surgical Management of NSCLC

Stage IV NSCLC

General NSCLC Clinical Guidance

Check out our other oncology-related content and sign up for alerts to stay informed on the latest published guidelines and insights.